Hao-Yuan Chuang
Chief Financial Officer at Belite Bio Inc
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 6 months
- Director since
- 2026
6 months of board service in total across 1 board, counting each seat separately. Longest: Belite Bio Inc, 6 months.
Belite Bio Inc
Director · Chief Financial Officer
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 8, 2026 | Belite Bio Inc | Open-market sale | −2,200 | $194.28 | $427,414 |
| Sep 8, 2026 | Belite Bio Inc | Open-market sale | −4,120 | $195.60 | $805,889 |
| Sep 8, 2026 | Belite Bio Inc | Open-market sale | −4,475 | $196.47 | $879,200 |
| Sep 8, 2026 | Belite Bio Inc | Open-market sale | −4,605 | $197.23 | $908,244 |
| Sep 8, 2026 | Belite Bio Inc | Open-market sale | −2,562 | $198.05 | $507,392 |
| Sep 4, 2026 | Belite Bio Inc | Open-market sale | −1,633 | $180.16 | $294,201 |
| Sep 4, 2026 | Belite Bio Inc | Open-market sale | −2,000 | $181.05 | $362,107 |
| Sep 4, 2026 | Belite Bio Inc | Open-market sale | −2,000 | $182.49 | $364,985 |
| Sep 4, 2026 | Belite Bio Inc | Open-market sale | −3,759 | $183.27 | $688,899 |
| Sep 4, 2026 | Belite Bio Inc | Open-market sale | −3,569 | $184.57 | $658,744 |
| Sep 4, 2026 | Belite Bio Inc | Open-market sale | −3,872 | $185.28 | $717,408 |
| Sep 4, 2026 | Belite Bio Inc | Open-market sale | −4,600 | $186.35 | $857,187 |
| Sep 4, 2026 | Belite Bio Inc | Open-market sale | −3,900 | $187.16 | $729,942 |
| Sep 4, 2026 | Belite Bio Inc | Open-market sale | −1,900 | $188.59 | $358,318 |
| Sep 4, 2026 | Belite Bio Inc | Open-market sale | −6,200 | $189.22 | $1,173,191 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.